Silver Book Fact

Between August 2004 and July 2014, the FDA approved:

  • Six new anticancer therapeutics
  • Five new uses for previously approved anticancer therapeutics
  • Two new uses for imaging agents
  • One new use for a screening test

AACR Cancer Progress Report 2014. Clin Cancer Res Web site. http://clincancerres.aacrjournals.org/content/20/19/4977.full. Published 2014

Reference

Title
AACR Cancer Progress Report 2014
Publication
Clin Cancer Res
Publication Date
Published 2014
Authors
American Association for Cancer Research
Volume & Issue
Volume 20, Issue S1
Pages
S1-S112
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • As of July 2014, 18 anticancer drugs received FDA approval after being designated breakthrough therapies.  
  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • From 1975 to 1996, new cancer drugs increased life expectancy of cancer patients by about one year, at an estimated cost of $3,000—well below the estimated value of a statistical…  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.  
  • In 1971, one in 69 people was a cancer survivor (three million survivors). In 2014, that number grew to one in 22 people (14.5 million survivors).